Open-label phase 1/2 study evaluating the tolerability and antitumor activity of selinexor and pembrolizumab in colorectal cancer von Golan, Talia, Shentzer Kutiel, Talia, Gottfried, Maya, Zer, Alona, Zick, Aviad, Shai, Ayelet, Ryvo, Larissa, Dudnik, Julia, Peled, Nir, Oberkovitz, Galia, Yang, Fan, Sharoni, Shmuel, Meng, Changting, Michel, Dayana, Sbar, Eric, Shah, Jatin J., Kauffman, Michael, Shacham, Sharon, Geva, Ravit

Volltext